Research graph
References from Association of atherogenic indices with myocardial damage and mortality in COVID-19. Local targets link to admitted publications; unresolved targets remain external evidence.
Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV
10.1002/jmv.25709 · 2020 · External reference
Emerging coronaviruses: Genome structure, replication, and pathogenesis
10.1002/jmv.25681 · 2020 · External reference
Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia
10.1080/22221751.2020.1746199 · 2020 · External reference
Cardiac manifestations of patients with COVID-19 pneumonia and related treatment recommendations.
2020 · External reference
Cardiovascular complications of severe acute respiratory syndrome.
10.1136/pgmj.2005.037515 · 2006 · External reference
Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis.
10.1016/j.tmaid.2020.101606 · 2020 · External reference
Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan
10.1001/jama.2020.1585 · 2020 · External reference
Clinical features of patients infected with 2019 novel coronavirus in Wuhan
10.1016/s0140-6736(20)30183-5 · 2020 · External reference
COVID-19: consider cytokine storm syndromes and immunosuppression
10.1016/s0140-6736(20)30628-0 · 2020 · External reference
Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China.
10.1016/j.chest.2020.04.010 · 2020 · External reference
Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function
10.1194/jlr.r083121 · 2018 · External reference
Sphingolipids and the formation of sterol-enriched ordered membrane domains
10.1016/j.bbamem.2006.05.020 · 2006 · External reference
Mevalonate pathway, selenoproteins, redox balance, immune system, Covid-19: Reasoning about connections.
10.1016/j.mehy.2020.110128 · 2020 · External reference
High-Density Lipoproteins Are Bug Scavengers.
10.3390/biom10040598 · 2020 · External reference
Lipid testing in infectious diseases: possible role in diagnosis and prognosis.
10.1007/s15010-017-1022-3 · 2017 · External reference
Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins
10.1194/jlr.m300228-jlr200 · 2003 · External reference
ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response
10.1016/s0022-2275(20)31690-4 · 2001 · External reference
Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation.
10.1007/s00134-009-1609-y · 2009 · External reference
Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients
10.1194/jlr.m200401-jlr200 · 2003 · External reference
Hypolipidemia is associated with the severity of COVID-19.
10.1016/j.jacl.2020.04.008 · 2020 · External reference
Letter to the editor: low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
10.1016/j.metabol.2020.154243 · 2020 · External reference
Low HDL and high triglycerides predict COVID-19 severity.
10.1038/s41598-021-86747-5 · 2021 · External reference
Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study
10.1186/s12944-020-01382-9 · 2020 · External reference
Summary estimates of cholesterol used to predict coronary heart disease
10.1161/01.cir.67.4.730 · 1983 · External reference
The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)).
10.1016/s0009-9120(01)00263-6 · 2001 · External reference
Atherogenic index of plasma, Castelli risk index and atherogenic coefficient- new parameters in assessing cardiovascular risk
2013 · External reference
Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study
10.2337/diacare.26.1.16 · 2003 · External reference
Unresolved reference
External reference
World Medical Association Declaration of Helsinki: ethica principles for medical research involving human subjects
10.1001/jama.2013.281053 · 2013 · External reference
Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases
10.1002/jcp.27028 · 2018 · External reference
The C-reactive protein/albumin ratio as an independent predictor of mortality in patients with severe sepsis or septic shock treated with early goal-directed therapy
10.1371/journal.pone.0132109 · 2015 · External reference
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan
10.1001/jamacardio.2020.0950 · 2020 · External reference
Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19).
10.1001/jamacardio.2020.1017 · 2020 · External reference
Combined use of the neutrophil-to-lymphocyte ratio and CRP to predict 7-day disease severity in 84 hospitalized patients with COVID-19 pneumonia: a retrospective cohort study.
10.21037/atm-20-2372 · 2020 · External reference
High-density lipoprotein and atherosclerosis: the role of antioxidant activity
10.1007/s11883-012-0235-2 · 2012 · External reference
10.1161/01.res.0000146094.59640.13
10.1161/01.res.0000146094.59640.13 · 2004 · External reference
High-Density Lipoproteins and Their Constituent, Sphingosine-1- Phosphate, Directly Protect the Heart against Ischemia/Reperfusion Injury In Vivo via the S1P 3 Lysophospholipid Receptor.
10.1161/circulationaha.105.607135 · 2006 · External reference
High-Density Lipoprotein Deficiency and Dyslipoproteinemia Associated with Venous Thrombosis in Men
10.1161/circulationaha.104.521344 · 2005 · External reference
Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper.
10.3389/fimmu.2020.01648 · 2020 · External reference
High-density Lipoprotein Suppresses the Type I Interferon Response, a Family of Potent Antiviral Immunoregulators, in Macrophages Challenged with Lipopolysaccharide
10.1161/circulationaha.110.961193 · 2010 · External reference
